Search Results

LY2940680 100mg 100mg  | Purity Not Available

Adooq Bioscience

LY2940680 has been shown to affect a cancer cell signaling pathway initiated by the Hedgehog (Hh) protein.

More Information Supplier Page

LY2940680 10mg 10mg  | Purity Not Available

Adooq Bioscience

LY2940680 has been shown to affect a cancer cell signaling pathway initiated by the Hedgehog (Hh) protein.

More Information Supplier Page

PHA-848125 50mg 50mg  | Purity Not Available

Adooq Bioscience

PHA-848125 (Milciclib) is an orally bioavailable inhibitor of CDKs and TRKA with potential antineoplastic activity.

More Information Supplier Page

PHA-848125 5mg 5mg  | Purity Not Available

Adooq Bioscience

PHA-848125 (Milciclib) is an orally bioavailable inhibitor of CDKs and TRKA with potential antineoplastic activity.

More Information Supplier Page

PHA-848125 100mg 100mg  | Purity Not Available

Adooq Bioscience

PHA-848125 (Milciclib) is an orally bioavailable inhibitor of CDKs and TRKA with potential antineoplastic activity.

More Information Supplier Page

PHA-848125 10mg 10mg  | Purity Not Available

Adooq Bioscience

PHA-848125 (Milciclib) is an orally bioavailable inhibitor of CDKs and TRKA with potential antineoplastic activity.

More Information Supplier Page

INCB018424 5mg 5mg  | Purity Not Available

Adooq Bioscience

INCB018424 is a potent and selective inhibitor of Janus-associated kinase (JAK) 1 and 2, with IC50 to be 2.7, 4.5 and 332 nM for JAK1, JAK2 and JAK3 respectively;

More Information Supplier Page

INCB018424 25mg 25mg  | Purity Not Available

Adooq Bioscience

INCB018424 is a potent and selective inhibitor of Janus-associated kinase (JAK) 1 and 2, with IC50 to be 2.7, 4.5 and 332 nM for JAK1, JAK2 and JAK3 respectively;

More Information Supplier Page